Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heartbeam, Inc. - Common Stock
(NQ:
BEAT
)
1.960
-0.040 (-2.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heartbeam, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures Additional IP Protection for Breakthrough ECG Patch Technology
September 15, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Why Heartbeam Shares Are Skyrocketing 75% Higher
September 15, 2022
Heartbeam Inc (NASDAQ: BEAT) shares are trading higher by 76% to $2.20 Thursday morning after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of...
Via
Benzinga
HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias
September 15, 2022
From
HeartBeam, Inc.
Via
Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Unveil Platform Technology in Virtual Roadshow Webinar
September 12, 2022
Via
Investor Brand Network
Topics
Credit Cards
Exposures
Interest Rates
Product Safety
HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time
September 12, 2022
From
HeartBeam, Inc.
Via
Business Wire
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 16, 2022
Via
Benzinga
HeartBeam Announces FDA Submission of HeartBeam AIMI™ Product
August 16, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Reports Second Quarter 2022 Financial Results
August 11, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Names Ken Persen as Chief Technology Officer
August 04, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Wins CVI 2022 Innovation Summit Award
July 28, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time
July 26, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Expands Patient Population for Emergency Department Software Technology Solution
June 30, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022
May 25, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022
May 18, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Reports First Quarter 2022 Financial Results
May 12, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time
April 28, 2022
From
HeartBeam, Inc.
Via
Business Wire
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 21, 2022
Gainers
Via
Benzinga
HeartBeam to Host Virtual Roadshow Webinar on Wednesday April 27, 2022 at 11:30 a.m. Eastern Time
April 19, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Reports Fourth Quarter and Full Year 2021 Financial Results
March 24, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam, Triple Ring To Co-Develop Telehealth Solution Device For Heart Attack Monitoring
March 10, 2022
HeartBeam Inc (NASDAQ: BEAT) has signed a professional services agreement with Triple Ring Technologies Inc to assist in the design and development of...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 04, 2022
Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...
Via
Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...
Via
Benzinga
21 Stocks Moving in Thursday's Pre-Market Session
February 03, 2022
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Also check out: Executives sell over $20 million of 5 stocks...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 17, 2022
On Thursday, 147 companies achieved new lows for the year. Significant Points From Today's 52-Week Lows: PayPal Holdings (NASDAQ:PYPL) was the biggest company...
Via
Benzinga
HeartBeam Partners with LIVMOR for Cloud Based Remote Monitoring Portal
February 02, 2022
From
HeartBeam, Inc.
Via
Business Wire
HeartBeam Establishes Scientific Advisory Board and Appoints C. Michael Gibson, MD as Chairman
January 27, 2022
From
HeartBeam, Inc.
Via
Business Wire
10 Low-Float Penny Stocks for Steel-Gutted Investors
January 11, 2022
If you’re willing to absorb massive risk for the chance of significant upside, these low-float penny stocks could fit the bill.
Via
InvestorPlace
HeartBeam to Participate in the H.C. Wainwright BIOCONNECT Conference
December 29, 2021
From
HeartBeam, Inc.
Via
Business Wire
61 Biggest Movers From Yesterday
January 04, 2022
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.